Health Login | Sign Up
This article is expired, comments are disabled.
Merck wins European approval to market first-ever Ebola vaccine
U.S. drugmaker Merck & Co Inc on Monday received approval from the European Commission to market its Ebola vaccine.
(C) Canadian Broadcasting Corporation
Share
Home > All News > Health